NL-OMON27702CompletedNot Applicable
Retreatment of chronic hepatitis C patients with pegylated interferon, ribavirin and amantadine; A pilot study to establishif initial drop in viral load is predictive for sustained virological response.
Schering-Plough0 sites61 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 61
Study Overview
Brief Summary
/A
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1. Patients with a chronic HCV infection, with virological relapse, or with virological non response to previous antiviral therapy diagnosed by:
- •a. anti-HCV positive;
Exclusion Criteria
- •1. Patients who are pregnant and patients (male or female) who are not willing to practise adequate contraception during the treatment period and up to 6 months after ending the treatment period;
- •2. Patients who are HBsAg or HIV antibody positive or are unwilling to have these tests done;
Investigators
Similar Trials
Completed
Not Applicable
TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C (HCC) USING PEG-INTERFERON ALPHA 2B AND RIBAVIRINEPER-039-01SCHERING PLOUGH RESEARCH INSTITUTE,
Completed
Not Applicable
Retreatment of chronic hepatitis C patients with pegylated interferon (IFN), ribavirin and amantadine; a pilot study to establish if initial drop in viral load is predictive for sustained virological responseHepatitis CISRCTN81536220Academic Medical Center (AMC), Department of Gastroenterology, AMC Liver Center (The Netherlands)100
Active, not recruiting
Not Applicable
Evaluation of chronic hepatitis C treatment with PEG-IFN ALFA-2a and ribavirin in HIV-positive subjects with persistently normal transaminase levels. - Treatment of co-infected patients with normal ALTTreatment of adult patients with hystologically demonstrated chronic C hepatitis without hepatic failure and HCV-RNA positive, treatment of patients with normal ALT and with HIV/HCV co-infection.MedDRA version: 9.1Level: LLTClassification code 10019744Term: Hepatitis CEUCTR2007-005698-76-ITAZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE)
Unknown
Phase 4
Pegylated-Interferon and Ribavirin in Hepatitis C Patients With Persistently Normal Alanine Aminotransferase LevelsChronic Hepatitis CNCT00575627University of Turin, Italy150
Unknown
Not Applicable
HCV Treatment in a Low-threshold ClinicSubstance Use DisordersHepatitis CNCT04063839University Hospital, Akershus300